Genomic imprinting
(Redirected from Genomic Imprinting)
Genomic Imprinting is a unique process of gene regulation in which the expression of a gene depends upon the parent from whom it was inherited. It is an exception to the usual rules of inheritance and plays a crucial role in development.
Overview[edit | edit source]
Genomic imprinting involves the silencing of a gene by the addition of a methyl group (a process known as methylation), which prevents the gene from being expressed. This silencing can occur in either the maternal or paternal copy of a gene, depending on the specific gene involved.
Mechanism[edit | edit source]
The mechanism of genomic imprinting is complex and not fully understood. It is known to involve DNA methylation and histone modification, which are two key processes in the regulation of gene expression. The imprinting process begins in the germ cells (sperm and egg cells) and continues throughout the life of the organism.
Diseases and Disorders[edit | edit source]
Abnormalities in genomic imprinting can lead to a number of diseases and disorders. These include Prader-Willi syndrome, Angelman syndrome, and Beckwith-Wiedemann syndrome, among others. In many of these conditions, the symptoms vary depending on whether the mutation is in the maternal or paternal copy of the gene.
Research and Future Directions[edit | edit source]
Research into genomic imprinting is ongoing, with scientists seeking to understand the precise mechanisms involved and the implications for human health and disease. This research has potential implications for the treatment of a range of diseases, including cancer, neurological disorders, and developmental disorders.
See Also[edit | edit source]
- Epigenetics
- DNA methylation
- Histone modification
- Prader-Willi syndrome
- Angelman syndrome
- Beckwith-Wiedemann syndrome
Genomic imprinting Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Kondreddy Naveen